| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.48 | 5e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |